Treatment Effect Sizes of Once-Daily Valbenazine for Tardive Dyskinesia and for Chorea Associated with Huntington’s Disease: A Post-Hoc Analysis of Phase 3 Clinical Trial Data
Objective: To assess the treatment effect size of once-daily valbenazine for tardive dyskinesia (TD) and for chorea associated with Huntington’s disease (HD) using data from…Deciphering the Huntington’s Disease Research Landscape: A Comprehensive Bibliometric and Trend Analysis
Objective: To map the Huntington's Disease research landscape, identifying key trends, gaps, and the most impactful studies to guide future research directions and therapeutic strategies.…Mapping the Efficacy Landscape: A Network Meta-Analysis of Pharmacological Interventions in Huntington’s Disease
Objective: To evaluate and compare the efficacy of pharmacological interventions for Huntington's Disease through a network meta-analysis, identifying the most effective treatments. Background: Huntington’s Disease…Huntington’s Disease Pathogenesis, Molecular Factors, and Potential for Combinatorial Therapies: A Focus on BDNF and NMDA Receptor Therapies
Objective: This paper outlines current therapeutic options for HD, and ultimately suggests taking a combinatorial therapeutic approach to slow HD progression by simultaneously treating multiple…Shifting Paradigms In Huntington’s Disease Research: A Five-Year Scopus-Based Bibliometric Exploration
Objective: This study aimed to investigate the shifting trends (2019-2024) in research on Huntington's disease (HD)based on bibliometric lens. Background: Huntington's disease is a movement…Exploring the Impact of Mechanoacoustic Vibration Therapy on Mobility, Bone Density, and Postural Stability in Perimenopause Women with Huntington’s disease
Objective: This study aimed to investigate the effects of mechanoacoustic vibration therapy on mobility, bone mineral density (BMD), and postural instability in perimenopause women with…Patient and Caregiver Experiences with Huntington Disease: Emotions, Challenges, and Unmet Needs in the Patient Journey
Objective: To describe patients' emotional journey from symptom onset and diagnosis to current state and to identify challenges and unmet needs in Huntington disease (HD).…Patient Reported Outcomes of Using a Chaplain Service in a Huntington’s Disease Clinic
Objective: To better understand and describe the impact of providing spiritual care, in the form of a chaplain service, to patients being seen in a…TeleHD: Feasibility, Validity and Value of Telemedicine in Huntington Disease
Objective: To demonstrate the feasibility of conducting telemedicine visits, establish the validity and reliability of tele-administered motor/non-motor assessments, and determine the satisfaction of virtual visits…A case of trichotillomania as the preceding symptom of Huntington’ s diseaseand the effect of risperidone
Objective: Huntington's disease (HD) is a rare neurodegenerative disorder inherited by an autosomal dominant fashion which is most commonly characterised by choreic movement disorders. However,…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 11
- Next Page »